Skip to main content

Table 2 Main characteristics of the prognostic studies

From: CircRNAs in diagnosis, prognosis, and clinicopathological features of multiple myeloma; a systematic review and meta-analysis

Author’s name

Year

CircRNAs

(n = 13)

MMa patiens

size

Sample type

Method

Survival indicator (OSb)

HR

Extraction

Follow

up*

NOSe

HRc (95% CId)

P value

Fang Chen

2020

Circ-0069767

66

Bone marrow

qRT-PCR

0.22 (0.1–0.47)

0.0001

Indirectly

60

7

Hongyan Ma

2022

Circ-PSAP

50

Bone marrow

qRT-PCR

3.39 (0.99–3.88)

/

Indirectly

60

7

Haiyan Liu

2019

Circ-SMARCA5

105

Bone marrow

qRT-PCR

0.259 (0.119–0.565)

0.001

Directly

40

8

Lin Liu

2021

Circ-0001821

115

Bone marrow

qRT-PCR

2.342 (1.217–4.355)

0.031

Directly

60

8

Fang Chen

2020

Circ-CDYL

72

Bone marrow

and PBf

qRT-PCR

3.49 (1.59–7.60)

0.0017

Indirectly

60

7

Hui Zhou

2019

Circ-ITCH

92

Bone marrow

qRT-PCR

0.367 (0.156–0.865)

0.018

Directly

36

8

Xingxing Gong

2021

Circ- 0087776

136

PB

(serum)

qRT-PCR

4.228 (2.564–6.974)

0.001

Directly

–

7

Shanshan Yu

2020

Circ‑

MYBL2

89

Bone marrow

and serum

qRT-PCR

0.37 (0.18–0.74)

0.0052

Indirectly

50

6

Yanwei Luo

2020

Circ-MYC

122

PB

(serum)

qRT-PCR

3.67 (1.65–5.58)

0.0001

Directly

60

8

Xiao Liu

2020

Circ-101,237

143

Bone marrow

qRT-PCR

4.22 (1.05–3.71)

0.035

Indirectly

60

7

Fan Zhou

2021

Circ-PTK2

60

Bone marrow

qRT-PCR

3.89 (1.54–9.79)

0.004

Indirectly

40

6

Fan Zhou

2021

Circ-AFF2

60

Bone marrow

qRT-PCR

0.29 (0.15–0.65)

0.003

Indirectly

40

6

Yan Li

2022

Circ-KCNQ5

43

Bone marrow

qRT-PCR

7.96 (2.65–23.80)

0.0001

Indirectly

60

8

  1. a Multiple myeloma; b Overall survival; c Hazard ratio; d 95% confidence interval; e Newcastle-Ottawa Scale; f Peripheral blood
  2. * Months